Scholar Rock Holding (SRRK) Accumulated Expenses (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Accumulated Expenses came in at $44.3 million in Q1 2026, up 428.85% year-on-year from $8.4 million in Q1 2025, and up 12.09% quarter-over-quarter from $39.6 million in Q4 2025.

Scholar Rock Holding (SRRK) Accumulated Expenses (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Accumulated Expenses history runs 10 years deep, the most recent figure standing at $44.3 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 428.85% year-over-year to $44.3 million in Q1 2026; TTM through Mar 2026 was $44.3 million, a 428.85% increase from a year earlier, with the FY2025 full-year figure at $39.6 million, up 167.77% from the prior year.
  • Accumulated Expenses rose to $44.3 million in Q1 2026 per SRRK's latest filing, from $39.6 million in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $49.9 million in Q3 2025 and bottomed at $200000.0 in Q3 2022.
  • The 5-year median for Accumulated Expenses is $14.7 million (2025), against an average of $17.1 million.
  • Across the five-year window, Accumulated Expenses plunged 98.88% in 2022 and surged 8598.5% in 2023, its largest moves.
  • Year by year, Accumulated Expenses stood at $6.8 million in 2022, then jumped by 55.75% to $10.6 million in 2023, then jumped by 39.51% to $14.8 million in 2024, then jumped by 167.77% to $39.6 million in 2025, then grew by 12.09% to $44.3 million in 2026.
  • Per Business Quant, the three latest SRRK Accumulated Expenses figures stand at $44.3 million (Q1 2026), $39.6 million (Q4 2025), and $49.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Scholar Rock Holding 6.30 Bn 6.30 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 44.35 Mn
Dec 31, 2025 39.57 Mn
Sep 30, 2025 49.88 Mn
Jun 30, 2025 14.69 Mn
Mar 31, 2025 8.39 Mn
Dec 31, 2024 14.78 Mn
Sep 30, 2024 29.26 Mn
Jun 30, 2024 21.89 Mn
Mar 31, 2024 6.11 Mn
Dec 31, 2023 10.59 Mn
Sep 30, 2023 17.40 Mn
Jun 30, 2023 5.63 Mn
Mar 31, 2023 14.73 Mn
Dec 31, 2022 6.80 Mn
Sep 30, 2022 200,000.00
Jun 30, 2022 1.40 Mn
Mar 31, 2022 4.47 Mn
Dec 31, 2021 7.15 Mn
Sep 30, 2021 17.90 Mn
Jun 30, 2021 15.45 Mn